HIV/AIDS Series: Treatment for HIV - Part 1

1. Untitled Scene
- 1.1. Opening
- 1.2. Title
- 1.3. Acknowledgment
- 1.4. Note
- 1.5. Learning Objectives
- 1.6. Introduction
- 1.7. Introduction (continued)
- 1.8. World Health Organization Guidelines
- 1.9. Deciding Whether to Start Therapy for HIV
- 1.10. Antiretroviral Therapy — When to Start ART
- 1.11. Deciding Whether to Start Therapy for HIV (continued)
- 1.12. Symptoms (Clinical Status) of HIV
- 1.13. CD4 Count and Viral Load
- 1.14. CD4 Count and Viral Load (continued)
- 1.15. Quiz 1
- 1.16. Other Existing Medical Conditions
- 1.17. Adherence to Treatment
- 1.18. Adherence to Treatment (continued)
- 1.19. Risk of Transmitting HIV to Sexual Partners
- 1.20. New Section
- 1.21. Deciding What Drugs to Take
- 1.22. Available Anti-HIV Drugs
- 1.23. Available Anti-HIV Drugs (continued)
- 1.24. Available Anti-HIV Drugs (continued)
- 1.25. Nucleoside Reverse Transcriptase Inhibitors (NRTIs or Nukes)
- 1.26. Quiz 2
- 1.27. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs or Non-Nukes)
- 1.28. Protease Inhibitors (PIs)
- 1.29. Integrase Inhibitors
- 1.30. Fusion or Entry Inhibitors
- 1.31. Chemokine Coreceptor Antagonists (CCR5)
- 1.32. Multi-Class Drug Combinations
- 1.33. Which Drugs Should You Take?
- 1.34. Which Drugs Should You Take? (continued)
- 1.35. Combination Therapy
- 1.36. Combination Therapy (continued)
- 1.37. Why You Must Stay On the Treatment Plan
- 1.38. Why You Must Stay On the Treatment Plan (continued)
- 1.39. Why You Must Stay On the Treatment Plan (continued)
- 1.40. Quiz 3
- 1.41. Tips for Staying On Your Treatment Plan
- 1.42. Tips for Staying On Your Treatment Plan (continued)
- 1.43. Decision Slide
- 1.44. Disclaimer
2. Information
- 2.1. WiRED International
3. Untitled Scene

Additional information:

HIV/AIDS Glossary
Managing Side Effects
Guidelines on the Use of Antiretroviral Drugs
Guidelines on HIV Prevention, Diagnosis, Treatment and Care